(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.
Korro Bio's earnings in 2025 is -$87,411,000.On average, 7 Wall Street analysts forecast KRRO's earnings for 2025 to be -$94,871,202, with the lowest KRRO earnings forecast at -$112,216,379, and the highest KRRO earnings forecast at -$81,603,375. On average, 5 Wall Street analysts forecast KRRO's earnings for 2026 to be -$79,499,905, with the lowest KRRO earnings forecast at -$118,414,104, and the highest KRRO earnings forecast at -$52,962,375.
In 2027, KRRO is forecast to generate -$98,224,546 in earnings, with the lowest earnings forecast at -$125,926,498 and the highest earnings forecast at -$59,160,100.